Parainfluenza
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Parainfluenza

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Parainfluenza Local Doctors?
Elite in Parainfluenza
Elite in Parainfluenza
Referral may be required
Bissau, GN 

Peter Aaby practices practicing medicine in Bissau, Guinea. Mr. Aaby is rated as an Elite expert by MediFind in the treatment of Parainfluenza. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Measles, Parainfluenza, Tetanus, and Smallpox.

Elite in Parainfluenza
Internal Medicine
Elite in Parainfluenza
Internal Medicine

Office

473 Via Ortega # Y2, 
Stanford, CA 
Languages Spoken:
English

Stephen Luby is a primary care provider, practicing in Internal Medicine in Stanford, California. Dr. Luby is rated as an Elite provider by MediFind in the treatment of Parainfluenza. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Diarrhea, Parainfluenza, Typhoid Fever, and Salmonella Enterocolitis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Parainfluenza
Infectious Disease
Elite in Parainfluenza
Infectious Disease
Referral may be required

Rochester General Hospital

1425 Portland Ave, 
Rochester, NY 
Languages Spoken:
English

Ann Falsey is an Infectious Disease provider practicing medicine in Rochester, New York. Dr. Falsey is rated as an Elite provider by MediFind in the treatment of Parainfluenza. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Flu, and Severe Acute Respiratory Syndrome (SARS).

What are the latest Parainfluenza Clinical Trials?
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Deurremidevir Hydrobromide for Oral Suspension in Infants and Young Children With Respiratory Syncytial Virus Infection

Summary: This is a randomized, double-blind, placebo-controlled, parallel-group trial conducted in infants and young children aged 1 to 36 months with RSV infection. A total of 498 subjects are expected to be enrolled and randomly assigned to the investigational product group or the placebo group in a 2:1 ratio; Administration will be based on the subject's weight, with a dose of 20 mg/kg three times daily...

Match to trials
Find the right clinical trials for you in under a minute
Get started